Injection Desmopressin

In the modern clinical diagnosis and treatment system, the precise application of various drugs is the core support for improving diagnosis and treatment efficiency and improving patient prognosis. Among them, drugs with dual value of intervention and diagnosis occupy an important position in specific disease management due to their unique advantages.

Injection desmopressin is a typical representative of this type of drug. As a highly targeted bioactive substance, this drug plays an irreplaceable clinical role in the two core areas of hemorrhage tendency intervention and renal function diagnosis by precisely regulating the body's hemostasis system and physiological processes related to renal water metabolism. Compared with conventional drugs, its application scenarios are highly targeted, and its action characteristics also show significant uniqueness. It can accurately adapt to the intervention needs of specific diseases, and provide reliable technical support for clinical diagnosis. It provides important assistance for clinicians to develop scientific diagnosis and treatment plans and optimize diagnosis and treatment processes. The following will provide a detailed analysis from multiple dimensions and deep levels to clarify its specific application scenarios and core characteristics.

 

Our Product Forms

 

​

Desmopressin COA

Certificate of Analysis
Compound name	Desmopressin
Grade	Pharmaceutical grade
CAS No.	16679-58-6
Quantity	36g
Packaging standard	PE bag+Al foil bag
Manufacturer	Shaanxi BLOOM TECH Co., Ltd
Lot No.	202601090082
MFG	Jan 9th 2026
EXP	Jan 8th 2029
Structure
Item	Enterprise standard	Analysis result
Appearance	White or almost white powder	Conformed
Water content	≤5.0%	0.54%
Loss on drying	≤1.0%	0.42%
Heavy Metals	Pb≤0.5ppm	N.D.
	As≤0.5ppm	N.D.
	Hg≤0.5ppm	N.D.
	Cd≤0.5ppm	N.D.
Purity (HPLC)	≥99.0%	99.98%
Single impurity	<0.8%	0.52%
Total microbial count	≤750cfu/g	95
E. Coli	≤2MPN/g	N.D.
Salmonella	N.D.	N.D.
Ethanol (by GC)	≤5000ppm	500ppm
Storage	Store in a sealed, dark, and dry place at 0°C

Clinical intervention application of hemorrhage and hemorrhage tendency

Injection desmopressin is suitable for various specific scenarios in the clinical intervention of hemorrhage and hemorrhage tendency due to its targeted action characteristics, especially for the regulation of mild to moderate hemorrhage related diseases. At the same time, it can effectively prevent hemorrhage risks in various invasive procedures. The specific application scenarios and characteristics are as follows:

01.Intervention for mild to moderate factor VIII deficiency
factor VIII deficiency, as a hereditary hemostasis disorder, is characterized by insufficient synthesis or activity defects of hemostatic factor VIII. Its clinical manifestations include spontaneous hemorrhage or persistent hemorrhage after minor trauma, and it is commonly found in joints, mucous membranes, and soft tissues. Acetic acid antidiuretic hormone can stimulate relevant cells in the body to release hemostatic factor VIII, significantly increasing the activity level of this factor in peripheral blood, thereby compensating for the factor deficiency in the patient's body and achieving the goal of controlling hemorrhage and relieving symptoms. This application scenario has clear adaptability and is only suitable for mild to moderate patients. These patients still retain a certain ability to synthesize hemostatic factors, and drugs can be effectively regulated through moderate stimulation without relying on exogenous factor infusion. Compared with traditional intervention methods, it is more convenient and less likely to cause immune related adverse reactions. At the same time, it can reduce the impact of hemorrhage events on patients' joint function and quality of life.

02.Intervention for vascular haemophilia
Von Willebrand originates from the abnormal quantity or functional defects of von Willebrand factor, which is a key substance in the hemostasis process. This factor can mediate platelet adhesion, aggregation, and protect hemostatic factor VIII from degradation. Its abnormalities can lead to a significant tendency for hemorrhage in patients, mainly manifested as skin bruising and mucosal hemorrhage.Injection desmopressin can effectively promote the release and storage of von Willebrand factor and hemostatic factor VIII by endothelial cells, simultaneously increasing the peripheral blood concentration of both substances and improving the hemostasis function of patients. It is particularly suitable for daily hemorrhage control and perioperative hemorrhage prevention in patients with mild to moderate von Willebrand disease. This intervention method has the characteristics of strong targeting and rapid onset. After administration, it can quickly increase the levels of relevant factors, timely curb hemorrhage symptoms, and flexibly adjust the timing and method of administration according to the patient's hemorrhage situation, adapting to individual differences of different patients.

The source of information adopted in the above section are:

Li Li, Zhao Yang Observation of the therapeutic effect of antidiuretic hormone acetate in preventing hemorrhage during small and medium-sized surgeries Journal of Clinical surgical operation, 2022, 30 (10): 987-990
Garcí a R, et al. This Acetate: A Review of Its Role in Hemostasis and Renal Function Diagnosis. Drugs, 2022, 82(12): 1345-1362.

Prevention and control of hemorrhage in surgical and tooth extraction scenarios

Invasive procedures such as surgical operation and tooth extraction inevitably damage the blood vessels of the body. For patients with abnormal hemostasis function or hemorrhage tendency, such operations can easily cause significant intraoperative hemorrhage or continuous postoperative hemorrhage, increasing the risk of diagnosis and treatment.

Injection desmopressin can be used as a preventive intervention for such scenarios. By administering it reasonably before surgical operation, the activity of hemostasis related factors in the patient's body can be increased in advance, enhancing the body's hemostasis ability and reducing the total amount of intraoperative hemorrhage; For hemorrhage symptoms that have occurred during and after surgical operation, timely administration of medication can be used to quickly regulate hemostasis function, curb hemorrhage, and promote wound hemostasis and healing. Its application scenarios cover various small and medium-sized surgeries as well as oral extraction operations, especially suitable for patients with mild hemostasis dysfunction. The main reasons for this are reflected in the following aspects:

The drug's strength of action is suitable for mild abnormalities and does not require excessive intervention.

Patients with this condition have not completely lost their hemostasis system function and only have mild deficiency in hemostatic factor activity or a small amount of vascular haemophilia factor deficiency. Acetate antidiuretic hormone can gently stimulate the body to release relevant hemostatic factors, which precisely compensates for the mild deficiency, without excessive hemostasis or insufficient hemostasis;

Avoiding the adverse reactions of severe intervention, the safety is higher.

Compared with the exogenous hemostatic factor infusion required for severe patients, this drug does not require the introduction of exogenous substances, greatly reducing the risks of immune rejection, antibody production, etc. It is more suitable for short-term intervention or long-term maintenance of mild abnormal patients;

Convenient administration, suitable for the diagnosis and treatment of mild abnormal patients.

It can quickly take effect through short-term preoperative administration, easy operation, no need for long-term hospitalization monitoring, and meets the needs of "on-demand intervention and rapid hemostasis"; The fourth is to avoid overtreatment, reduce medical costs and physical burden, achieve temporary hemostasis or prevention effect with a single dose, without the need for long-term medication, and reduce medical expenses and potential burden of drugs on liver and kidney function.

Miller A, et al. Role of this Acetate in the Differential Diagnosis of Diabetes Insipidus: A Clinical Practice Update. Endocrinology and Metabolism Clinics of North America, 2023, 52(3): 567-582.
Liu Jing, Wang Hao The clinical application value of the acetate antidiuretic hormone  test in evaluating renal concentration function Chinese Journal of Practical Internal Medicine, 2022, 42 (8): 689-692

References

Hoffmann M, et al. Efficacy and Safety of Acetate in Mild to Moderate factor VIII deficiency: A Multicenter Retrospective Study. Journal of Thrombosis and Haemostasis, 2022, 20(7): 1689-1700.
Zhang Min, Li Juan Observation of the application of antidiuretic hormone acetate in perioperative hemorrhage management of patients with haemophilia Chinese Journal of Hemorheology, 2023, 33 (2): 215-218
de Jong J, et al. Desmopressin for hemorrhage Prophylaxis in Dental Extractions: A Randomized Controlled Trial. Journal of Oral and Maxillofacial surgical operation, 2021, 79(11): 2456-2465.
Peterson L, et al. Desmopressin in the Management of Spontaneous hemorrhage in Patients with Type 1 Von Willebrand Disease. Haemophilia, 2021, 27(4): 678-685.
Schmidt C, et al. Renal Concentrating Capacity Assessment Using Desmopressin in Elderly Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 2023, 38(5): 890-897.

FAQ

• What is the mechanism of action of this?

Basolateral membrane of the collecting duct in the kidneys –> insertion of aquaporin (AQP-2) water channels into the apical membrane –> increases water reabsorption. Vascular endothelium –> releases von Willebrand factor and factor VIII –> Reduces hemorrhage time.

• Is this antidiuretic?

Desmopressin (dDAVP), a synthetic analogue of 8-arginine antidiuretic hormone(ADH), is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine. ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body.

• Does it stop you from peeing?

Desmopressin is a medicine which 'tops up' the body's levels of the hormone antidiuretic hormone. This is the hormone which tells the kidneys to produce less wee at night. Most people sleep all night without needing a wee because of this hormone.

Hot Tags: injection desmopressin, China injection desmopressin manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, best glp1 for weight loss, glp1 shot, etelcalcetide structure